Skip to main content
Neoplasia (New York, N.Y.) logoLink to Neoplasia (New York, N.Y.)
. 2017 Feb 28;19(3):252–254. doi: 10.1016/j.neo.2016.12.013

Corrigendum to “Degradation of Epidermal Growth Factor Receptor Mediates Dasatinib-Induced Apoptosis in Head and Neck Squamous Cell Carcinoma Cells” [Neoplasia 14 (2012) 463–475]

Yu-Chin Lin *,,†,,‡, Meng-Hsuan Wu *, Tzu-Tang Wei *, Shu-Hui Chuang *, Kuen-Feng Chen §,,, Ann-Lii Cheng †,,§,,#, Ching-Chow Chen *,⁎
PMCID: PMC6414733  PMID: 28254153

In Figure 2, the Src band in the Western blot of FaDu was wrongly placed and we have revised it (arrow) in the new Figure 2 (below).

Figure 2.

Figure 2

Effect of dasatinib on Src, Akt, Erk, and Bcl-2.

In Figure 5A, the expressions of p-EGFR, EGFR, and p-Erk in HSC3 cells were wrongly placed and we have revised them (arrows) in the new Figure 5 (below).

Figure 5.

Figure 5

Role of EGFR in dasatinib-induced apoptosis.


Articles from Neoplasia (New York, N.Y.) are provided here courtesy of Neoplasia Press

RESOURCES